Amanda Grant Smith, M.D.

Transcription

1 Amanda Grant Smith, M.D. Office: University of South Florida Eric Pfeiffer Suncoast Alzheimer s & Gerontology Center At the USF Health Byrd Alzheimer s Institute 4001 E. Fletcher Avenue Tampa, Florida Phone: (813) Fax (813) asmith2@health.usf.edu Date of Birth: July 8, 1970 Place of Birth: Philadelphia, PA Maiden Name: Amanda Lauren Grant Social Security Number: Available upon request EDUCATION August 2001 September 2002 July 1998 August 2001 July 1997 June 1998 September 1993 May 1997 August 1992 May 1993 Fellowship in Geriatric Psychiatry University of South Florida College of Medicine Residency in General Psychiatry University of South Florida College of Medicine Internship in Psychiatry University of South Florida College of Medicine M.D. Jefferson Medical College of Thomas Jefferson University Philadelphia, PA Medical Science Track Program Hahnemann University Philadelphia, PA

2 August 1988 May 1992 B.A. in Psychology B.A. in Biology Emory University Atlanta, GA CERTIFICATION AND LICENSURE Diplomate of the American Board of Psychiatry and Neurology, Inc. May 2003 with Subspecialty Qualification in Geriatric Psychiatry April 2004 Florida License ME Federal DEA number available upon request CLINICAL APPOINTMENTS July 2009 present September 2008 July 2009 June 2008 August 2008 July 2004 May 2008 September 2002 July 2004 Medical Director USF Health Byrd Alzheimer s Center & Eric Pfeiffer Suncoast Alzheimer s & Gerontology Center University of South Florida Interim Director Eric Pfeiffer Suncoast Alzheimerʹs & Gerontology Center University of South Florida Acting Interim Director USF Suncoast Alzheimer s and Gerontology Center Assistant Director USF Suncoast Alzheimer s and Gerontology Center Faculty Physician USF Suncoast Gerontology Center ACADEMIC APPOINTMENTS September 2003 present Assistant Professor Department of Psychiatry and Behavioral Medicine

3 University of South Florida College of Medicine September 2002 September 2003 Visiting Instructor Department of Psychiatry and Behavioral Medicine University of South Florida College of Medicine HONORS AND AWARDS Class of 2007 January 2007 January 2006 January 2005 September 2003 October 2002 June 2001 November 2001 January 1999 November 2000 USF Health Leadership Institute Joseph and Dora Camden Memorial Award for Suncoast Alzheimer s and Gerontology Center s Most Valued Employee, 2006 Director s Award for Outstanding Service, Suncoast Alzheimer s and Gerontology Center Development Board Joseph and Dora Camden Memorial Award for Suncoast Alzheimer s and Gerontology Center s Most Valued Employee, 2004 Joseph and Dora Camden Memorial Award for Suncoast Gerontology Center s Most Valued Employee, July September 2003 Edith P. Freedman Fellowship Suncoast Gerontology Center Chairman s Award for Scholarly and Creative Activity Department of Psychiatry and Behavioral Medicine University of South Florida College of Medicine John Adams Award, Florida Psychiatric Society Ginsburg Fellow, Group for the Advancement of Psychiatry

4 ADMINISTRATIVE AND COMMITTEE POSITIONS February 2009 present 2008 present 2008 present July 2006 present Member, Subcommittee on consent of cognitively impaired subjects, USF Institutional Review Board Member, Steering Committee, Alzheimerʹs Disease Cooperative Study Member, USF Clinical and Translational Scientific Institute & Neuroscience Signature Program Protocol Review Committee Member, University of South Florida Institutional Review Board Medical Board IRB 01A Auction Chair, USF Suncoast Alzheimer s and Gerontology Center annual Victory Ball Site Representative, Steering Committee, Alzheimerʹs Disease Cooperative Study 2005 present Member, Executive Committee of the Development Board, USF Suncoast Alzheimer s and Gerontology Center Member, Recruitment Committee, Department of Psychiatry and Behavioral Medicine, USF College of Medicine 2004 present Member, Development Board, USF Suncoast Alzheimer s and Gerontology Center Member, Research Committee, Department of Psychiatry and Behavioral Medicine, USF College of Medicine Psychiatry Representative, CPE Advisory Committee, USF College of Medicine 2003 present 2002 present Member, Institute on Aging/Collaborative on Aging, USF Member, Executive Committee USF Suncoast Alzheimer s and Gerontology Center Psychiatry Representative, Utilization Review Committee

5 James A. Haley VA Medical Center, Fellow, Committee on Aging, Group for the Advancement of Psychiatry Member, Education Committee Department of Psychiatry and Behavioral Medicine University of South Florida College of Medicine RESEARCH ACTIVITIES 2010 Principal Investigator: A Controlled Pilot Study of the Appliation of Magnetic Fields Using the Resonator in Adjunctive Management of Alzheimer s Dementia. Pico Tesla Magnetic Therapies, LLC Study Physician: An Open Label, Non Randomized Study to Evaluate the Efficacy and Safety of BAY (ZK ) Positron Emission Tomography (PET) Imaging for Detection/Exclusion of Cerebral Beta Amyloid When Compared to Postmortem Histopathology. BHC Bayer Health Care Principal Investigator, Study physician: A Multi Center, Randomized, Double Blind, Placebo Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic effects of BMS in the Treatment of Patients with Prodromal Alzheimer s Disease. CN Bristol Myers Squibb Principal Investigator, Study physician: A Multi Center, Randomized, Double Blind, Placebo Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic effects of BMS in the Treatment of Patients with Mild to Moderate Alzheimer s Disease. CN Bristol Myers Squibb Sub investigator, Study physician. A Phase 3, Multi Center, Randomized, Double Blind Placebo Controlled Study to Evaluate the Safety and Tolerability of Dimebon (PF )

6 For Up to 26 Weeks in Patients With Mild to Moderate Alzheimer s Disease. B Pfizer Co Principal Investigator: Education Core of Florida ADRC. (William Haley PI) 2008 Principal Investigator, Study Physician: A Randomized, Double Blind, Placebo Controlled, Dose Ranging, Safety and Efficacy Study of Oral ELND005 (AZD 103) in Alzheimer s Disease. ELND005 AD201. Élan Pharmaceuticals, Inc Sub investigator, Study Physician: Effect of gamma Secretase Inhibition on the Progression of Alzheimer s Disease: LY Versus Placebo. Protocol H6L MC LFAN (b). Eli Lilly & Co Principal Investigator, Study Physician: A Double Blind, Placebo Controlled, Randomized, Multicenter Study Evaluating the Efficacy and Safety of Eighteen Months of Treatment with PF (TTP488) in Participants with Mild to Moderate Alzheimer s Disease. ADCS RAGE; Pfizer B Alzheimer s Disease Cooperative Study and Pfizer Principal Investigator (2008), Sub investigator, Study Physician: A Randomized, Double blind, Placebo controlled, Add on Three arm Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IVIG, 10%) for the Treatment of Mild to Moderate Alzheimer s Disease. ADCS GLAD; Baxter Alzheimer s Disease Cooperative Study and Baxter Healthcare Corporation Principal Investigator (2008), Sub investigator, Study Physician: A Phase III, Multicenter, Randomized, Double blind, Placebocontrolled, Parallel group, Efficacy and Safety Trial of Bapineuzumab (AAB 001, ELN115727) In Patients with Mild to Moderate Alzheimer s Disease who are Apolipoprotein E4 Noncarriers. ELN Élan Pharmaceuticals, Inc, & Wyeth Principal Investigator (2008), Sub investigator, Study Physician: A Phase III, Multicenter, Randomized, Double blind, Placebocontrolled, Parallel group, Efficacy and Safety Trial of

7 Bapineuzumab (AAB 001, ELN115727) In Patients with Mild to Moderate Alzheimer s Disease who are Apolipoprotein E4 Carriers. ELN Élan Pharmaceuticals, Inc, & Wyeth Principal Investigator (2008), Sub investigator, Study Physician: Open Label Study of the Effect of Daily Treatment with MPC 7869 in Subjects with Mild Dementia of the Alzheimer s Type. MPC Myriad Pharmaceuticals, Inc Principal Investigator (2008), Sub investigator, Study Physician: Multi Center Trial to Evaluate Home Based Assessment Methods for Alzheimer Disease Prevention Research in People Over 75 Years Old. ADC 030 HBA. Alzheimer s Disease Cooperative Study Principal Investigator (2008), Sub investigator, Study Physician: A Randomized Double Blind Placebo Controlled Trial of the Effects of Docosahexaenoic Acid (DHA) in Slowing the Progression of Alzheimer s Disease. ADC 027 DHA. Alzheimer s Disease Cooperative Study Principal Investigator (2008), Sub investigator, Study Physician: A Phase 3 Multinational, Randomized, Double blind, Placebocontrolled Study of the Effect of Daily Treatment with MPC 7869 on Measures of Cognition, Activities of Daily Living, and Global Function in Subjects with Mild Dementia of the Alzheimer s Type. MPC Myriad Pharmaceuticals, Inc Sub Investigator, Study Physician: A 54 week, Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy to Acetylcholinesterase Inhibitors on Cognition and Overall Clinical Response in APOE 4 Stratified Subjects with Mild to Moderate Alzheimer s Disease. AVA Glaxo SmithKline Sub investigator, Study Physician: An Open Label Extension Study Evaluating the Safety and Tolerability of Memantine in Patients with Moderate to Severe Dementia of the Alzheimer s Type. MEM MD 54. Forest Research Institute.

8 2006 Sub investigator, Study Physician: An Open Label Extension of the Phase III Study CL with Alzhemed TM in Patients with Alzheimer s Disease. Neurochem, Inc Sub investigator, Clinical and Education Cores. Florida ADRC. (NIA funded.) 2006 Sub Investigator, Study Physician: NTB Longitudinal Study. ELN AIP 901. Élan Pharmaceuticals, Inc Sub investigator, Study Physician: A Double Blind, Randomized, Placebo Controlled Study of the Efficacy, Safety and Tolerability of 8 week Treatment of Rozerem 8mg (QHS) in Sleep Disturbed, Community Dwelling, Mild to Moderately Severe Alzheimer s Disease Subjects TL Takeda Global Research and Development Center, Inc Sub investigator, Study Physician: A Multicenter, Randomized, Double Blind, Long Term Extension Study to Determine the Safety, Tolerability, and Preliminary Long Term Efficacy of Lecozotan (SRA 333) SR in Patients with Mild to Moderate Alzheimer s Disesase Treated with a Cholinesterase Inhibitor. 3098B1 204 WW. Wyeth Research Sub investigator, Study Physician: A 6 Month, Randomized, Double Blind, Placebo Controlled, Multicenter, Safety, Tolerability And Efficacy Study Of 3 Doses Of Lecozotan (SRA 333) SR In Outpatients With Mild To Moderate Alzheimer s Disease Treated with a Cholinesterase Inhibitor. 3098B1 203 WW. Wyeth Research Sub investigator, Study Physician: A Multicenter, Randomized, Double Blind, Long Term Extension Study to Determine the Safety, Tolerability, and Preliminary Long Term Efficacy of Lecozotan (SRA 333) SR in Patients with Mild to Moderate Alzheimer s Disesase. 3098B1 202 WW. Wyeth Research Sub investigator, Study Physician: A 3 Month, Randomized, Double Blind, Placebo Controlled, Multicenter, Safety,

9 Tolerability And Efficacy Study Of 3 Doses Of Lecozotan (SRA 333) SR In Outpatients With Mild To Moderate Alzheimer s Disease With Donepezil As Active Control. 3098B1 201 WW. Wyeth Research Sub investigator, Study Physician: An Exploratory Study with Open Label Memantine: Assessment of Selected Measures of Volumetric MRI and Cognition in Patients with Moderate Dementia of the Alzheimer s Type. MEM MD 15. Forest Research Institute 2005 Sub investigator, Study Physician: A Randomized, Double Blind, Placebo Controlled Evaluation of the Safety and Efficacy of Memantine in Patients with Moderate to Severe Dementia of the Alzheimer s Type. MEM MD 50. Forest Research Institute Principal Investigator (2008), Sub investigator, Study Physician: A Phase 3 Multicenter, Randomized, Double blind, Placebocontrolled Study of the Effect of Daily Treatment with MPC 7869 on Measures of Cognitive and Global Function in Subjects with Mild Dementia of the Alzheimer s Type. MPC Myriad Pharmaceuticals, Inc Sub investigator, Study Physician: A Phase III Study of the Efficacy and Safety of Alzhemed in Patients with Mild to Moderate Alzheimer s Disease. CL Neurochem, Inc Study Physician: Galantamine ER Open label Rapid Dose Escalation Trial in Alzheimer s Disease. GAL ALZ 303. Janssen Medical Affairs, L.L.C Principal Investigator (2008), Sub investigator, Clinical Study Coordinator, Study Physician: A Multi center, Double blind, Placebo controlled Therapeutic Trial to Determine Whether Natural Huperzine A Improves Cognitive Function. ADC 023 HU. Alzheimer s Disease Cooperative Study Study Physician: A Randomized, Multi center, Double blind, Placebo controlled, 18 month Study on Cognitive Function and Global Decline of Xaliproden in Comparison to Placebo in

10 Patients with Dementia of the Alzheimer s Type. EFC2946. Sanofi Synthelabo Research Study Physician: A One year, Multi center, Randomized, Placebo controlled Evaluation of the Efficacy and Safety of Donepezil Hydrochloride (E2020) in Subjects with Mild Cognitive Impairment. E2020 A Eisai/Pfizer Inc Study Physician: An Evaluation of the Long term Safety and Efficacy of Neramexane in Patients with Moderate to Severe Dementia of the Alzheimer s Type. NER MD 03. Forest Research Institute Study Physician: A Randomized, Double blind, Placebocontrolled Trial of Valproate to Attenuate the Progression of Alzheimer s Disease (AD). ADC 022 VN. Alzheimer s Disease Cooperative Study Clinical Study Coordinator, Study Physician: A Prospective, 26 Week, Open label, Single arm, Multi center Study Evaluating the Efficacy and Safety of Exelon (rivastigmine tartrate) 3 12mg/day in Patients with Mild to Moderate Alzheimer s Disease Who Are Responding Poorly to Aricept (donepezil) Treatment. CENA713BUS13. Novartis Pharmaceuticals Corp Clinical Study Coordinator, Study Physician: A Double Blind, Flexible Dose Comparison of the Safety and Efficacy of Escitalopram and Placebo in the Treatment of Geriatric Depression. SCT MD 13. Forest Research Institute Study Physician: High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer s Disease. ADC 016. Alzheimer s Disease Cooperative Study Study Physician: A Randomized, Double Blind, Placebo Controlled Evaluation of the Safety and Efficacy of Neramexane in Patients with Moderate to Severe Dementia of the Alzheimer s Type. NER MD 01. Forest Research Institute.

11 2003 Study Physician: A Randomized, Double Blind, Placebo Controlled Evaluation of the Safety and Efficacy of Neramexane in Patients with Moderate to Severe Dementia of the Alzheimer s Type. NER MD 02. Forest Research Institute Study Physician: A Multi center, Randomized, Double Blind, Placebo Controlled Trial of Simvastatin to Slow the Progression of Alzheimer s Disease. ADC 015. Alzheimer s Disease Cooperative Study Study Physician: A Phase II Double Blind, Randomized, Dose Ranging, Placebo Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer s Type Boehringer Ingelheim Pharmaceuticals, Inc Study Physician: A 24 Week, Multi center, Randomized, Doubleblind, Placebo controlled Evaluation of the Safety and Efficacy of Donepezil Hydrochloride (E2020) in Patients with Severe Alzheimer s Disease Followed by a 12 Week Open label Period. E2020 A Eisai/Pfizer Inc Study Physician, Rater: Comparative Effectiveness of Antipsychotic Medications in Patients with Alzheimer s Disease. Clinical Antipsychotic Trials in Intervention Effectiveness. NIMH contract #N01MH Study Physician: Efficacy and Safety of CX516 (900mg t.i.d.) in Elderly Participants with Mild Cognitive Impairment. A Randomized, Double blind, Placebo controlled, Parallel group 4 week study. CORX CX Cortex Pharmaceuticals Sub investigator; Clinical Study Coordinator: A Pilot Study of Dilute Tropicamide as a Non invasive Test for Alzheimer s Disease. (E. Pfeiffer and H. Potter, co PI s.) 2002 Study Physician: A Randomized, Double blind, Placebocontrolled Evaluation of the Safety and Efficacy of Memantine in Patients with Moderate to Severe Dementia of the Alzheimer s Type. MEM MD 01. Forest Research Institute.

12 2002 Study Physician: A Randomized, Double blind, Placebocontrolled Evaluation of the Safety and Efficacy of Memantine in Patients with Moderate to Severe Dementia of the Alzheimer s Type. MEM MD 02. Forest Research Institute Study Physician: A Long Term Extension Study Evaluating the Safety and Tolerability of Four Memantine Dosing Regimens in Patients with Moderate to Severe Dementia of the Alzheimer s Type. MEM MD 03. Forest Research Institute Study Physician: A Randomized, Double blind, Placebocontrolled Evaluation of the Safety and Efficacy of Memantine in Patients with Mild to Moderate Dementia of the Alzheimer s Type. MEM MD 12. Forest Research Institute Study Physician: Assessment Measures for Alzheimer s Disease Primary Prevention Trials. ADC 013. Alzheimer s Disease Cooperative Study Study Physician: The Safety and Efficacy of MK 0966 for the Prevention of Alzheimer s Disease in Patients at Risk. MK Merck & Co., Inc Study Physician: A Randomized, Double blind, Placebocontrolled Trial to Evaluate the Safety and Efficacy of Vitamin E and Donepezil HCl (Aricept) to Delay Clinical Progression from Mild Cognitive Impairment (MCI) to Alzheimer s Disease (AD). ADC 008. Alzheimer s Disease Cooperative Study University of South Florida Memory Disorders Clinic (Roskamp Institute) and USF Suncoast Gerontology Center,. Participant in interviews to screen patients for enrollment in research studies of dementia Grady Memorial Hospital MRI Center, Atlanta, GA. Research assistant to Emory University physics professor, Dr. John Malko. Studied cerebrospinal fluid using magnetic resonance imaging to find a standard by which to measure brain

13 atrophy in alcoholism and Alzheimer s disease. Studied effect of magnetic field on growth of yeast. OTHER SCHOLARLY ACTIVITY Dementia. James A. Haley VA Medical Center Geriatric Medicine Lecture series. September 12, New Directions in Alzheimer s Treatment and Research. 116 th Annual Convention of the Florida Pharmacy Association. July 12, Orlando, FL. New Directions in Alzheimer s Clinical Research. 10 th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Alzheimer s & Gerontology Center, USF Geriatric Education Center, USF School of Aging Studies, and USF College of Nursing. June 13, Advances in the Diagnosis and Treatment of Alzheimer s Disease. What Caregivers Need to Know sponsored by the USF Suncoast Gerontology Center. May 1, Plant City, FL Recognition and Management of Alzheimer s Disease and Related Dementias in the Skilled Nursing Facility. Florida chapter of the American Society of Consultant Pharmacists Annual Conference. April 12, Advances in the Diagnosis and Treatment of Alzheimer s Disease. What Caregivers Need to Know sponsored by Aston Gardens and the USF Suncoast Gerontology Center. February 28, Optimizing Pharmacotherapeutic Benefit in Alzheimer s Disease: Keys to Effective Disease Management. Meeting of the Florida chapter of the American Society of Consultant Pharmacists. January 29, Ft. Lauderdale, FL. Optimizing Pharmacotherapeutic Benefit in Alzheimer s Disease: Keys to Effective Disease Management. Meeting of the Florida chapter of the American Society of Consultant Pharmacists. January 23, Orlando, FL. Optimizing Pharmacotherapeutic Benefit in Alzheimer s Disease: Keys to Effective Disease Management. Meeting of the Florida chapter of the American Society of Consultant Pharmacists. January 22,

14 Dementia. Medical Student Psychiatry Interest Coalition. USF College of Medicine. December 5, Transdermal Therapy: A New Technology in Alzheimer s Disease. Meeting of the Greater Tampa Bay Psychiatric Society. November 7, Understanding Dementia. James A. Haley VA Medical Center Geriatric Medicine Lecture series. September 14, Treatment of Dementia and Related Behavioral Problems. Brandon Regional Hospital. September 12, Brandon, FL Understanding Dementia. 44 th Annual Conference of the Florida Association of Homes and Services for the Aging. July 31, Orlando, FL. Geriatric Case Conference on Dementia, 3 rd year medical student psychiatry clerkship. Every other month, June 2007 December Lewy Body Dementia. 9 th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Alzheimer s & Gerontology Center, USF Geriatric Education Center, USF School of Aging Studies, and USF College of Nursing. June 13, Medications for Treating Alzheimer s Disease and Behavior Management. Brandon Regional Hospital Lecture Series. February 21, Brandon, FL. Lifestyle Changes that May Prevent Alzheimer s Disease. USF Health Mini Med School. February 5, Tampa Bay Performing Arts Center,. Medications for Treating Alzheimer s Disease and Related Behavioral Problems. Palm Harbor Community Center Alzheimer s Support Group. January 22, Palm Harbor, FL Differentiating Dementia from Depression and Management of Behavioral Problems in Dementia. River Garden Hebrew Home Community Lecture Series in conjunction with the University of Florida, Gainesville. October 24, Jacksonville, FL. Advances in the Diagnosis and Treatment of Alzheimer s Disease. James A. Haley VA Medical Center Geriatric Medicine Lecture series. October 6,

15 When the Dementia Diagnosis Isn t Alzheimer s. Professional Guardian Association of Pinellas County Annual Conference. September 29, St. Petersburg, FL. Dealing with Alzheimer s Disease and Dementia: State of the Art Treatment and System Approaches. Panel discussion, Seniors in Florida: Protecting the Golden Years. A 21 st Century Summit. September 8, Outpatient clinical supervisor for ARNP Clinical Doctorate candidate. September 2006 Lifestyle Changes that May Prevent Alzheimer s Disease. 8 th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Gerontology Center, USF Geriatric Education Center, USF Department of Gerontology, and USF College of Nursing. June 8, Pharmacologic Approaches to Behavior Management in Dementia. 8 th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Gerontology Center, USF Geriatric Education Center, USF Department of Gerontology, and USF College of Nursing. June 8, Will a Healthy Lifestyle Prevent Alzheimer s Disease? University of South Florida Department of Psychiatry and Behavioral Medicine Geriatric Lecture series. January 27, Advances in the Diagnosis and Treatment of Alzheimer s Disease. University of South Florida Department of Psychiatry and Behavioral Medicine Grand Rounds. December 9, Advances in the Diagnosis and Treatment of Alzheimer s Disease. James A. Haley VA Medical Center Geriatric Medicine Lecture series. November 18, Alzheimer s 101. St. Petersburg MOAA chapter luncheon. September 16, St. Petersburg, FL. Outpatient clinical supervisor for Geriatric Medicine fellow. September 2005 The Cutting Edge: Alzheimer s Disease and Related Dementias. Journey through Aging sponsored by USF Lakeland. August 27, Lakeland, FL. Overview: Understanding Alzheimer s Disease. University of South Florida Employee Assistance Program Summer Workshop. July 26, Geriatric Case Discussion on Depression and Pseudodementia, 3 rd year medical student psychiatry clerkship. Every other month, June 2005 April 2007.

16 Grief and Its Effect on the Decision to Place a Demented Loved One in Long Term Care. Poster Presentation. Future Leaders in Psychiatry sponsored by Emory University School of Medicine. April 16, Palm Beach, FL. The Diagnosis and Management of Dementia. Neurology in the New Millennium sponsored by the USF Department of Neurology. October 30, Enrichment supervisor to PGY 3 psychiatry resident(s). Weekly, 2004 present. Thesis Director for undergraduate honors student at USF academic year. Alzheimer s 101 with Research Updates. Alzheimer s Disease Seminar for Caregivers and Professionals sponsored by the Alzheimer s Family Organization. September 8, Hudson, FL. When Memory Loss Is Not Alzheimer s: Understanding Depression and the Other Dementias. Alzheimer s Disease: What Health Professionals Need to Know sponsored by USF Suncoast Gerontology Center and Lakeland Regional Medical Center. December 2, Lakeland, FL. Thesis Director for undergraduate honors student at USF academic year. Management of Difficult Behavior Problems in Dementia. Alzheimer s Disease: What Caregivers Need to Know sponsored by USF Suncoast Gerontology Center. October 1, Psychiatric Management of Dementia. Strategies and Solutions in Geriatric Care. 5 th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Gerontology Center, USF Geriatric Education Center, USF Department of Gerontology, and USF College of Nursing. June 11, Geriatric psychiatry lectures on Geriatric Depression and Management of Behavioral Symptoms in Dementia. 3 rd year medical student psychiatry clerkship. Every other month, July 2003 June Outpatient clinical supervisor, 3 rd year medical student psychiatry clerkship, geriatric medicine outpatient clerkship, and 4 th year medical student psychiatry electives present. Alzheimer s Disease Update. Alzheimer s 2 nd Educational Seminar sponsored by Samaritans Alzheimer s Auxiliary. February 26, Sun City Center, FL.

17 Mealtime and Nutrition in the Middle and Late Stages. Alzheimer s Disease: What Caregivers Need to Know sponsored by USF Suncoast Gerontology Center. February 12, Eating Related Problems in Dementia Patients. University Village nursing home staff. November 19, Clinical supervisor to geriatric psychiatry fellow. Weekly, 2002 present. Topiramate Overdose: A Case Report and Literature Review. Fall meeting of the Florida Psychiatric Society. November 3, Miami, FL. Examiner for Clinical Practice Exercise. Department of Psychiatry and Behavioral Medicine, University of South Florida College of Medicine. Annually, 2000 present. Led small group seminars for first year medical students as part of their Introduction to Behavioral Medicine course. University of South Florida College of Medicine. Annually, PROFESSIONAL AFFILIATIONS American Association for Geriatric Psychiatry International Psychogeriatric Association Alzheimer s Association International Society to Advance Alzheimer Research and Treatment (ISTAART) Novartis Speaker s Bureau PUBLICATIONS Smith, AG: Why is the Room Spinning? The Tampa Tribune (4 You), January 3, Smith, AG: How Can Caregivers Take Care of Themselves? The Tampa Tribune (4 You), August 23, Smith, AG: Can Tiny Strokes Cause Memory Loss? The Tampa Tribune (4 You), May 31, Smith, AG: Do You Have To Tell Your Doctor Everything? The Tampa Tribune (4 You), March 1, Smith, AG: How Do I Get a Good Night s Sleep? The Tampa Tribune (4 You), November 10, 2007.

18 Smith, AG: How Can You Prevent Fall Related Injuries? The Tampa Tribune (4 You), August 11, Smith, AG: Coping with the Changes in Medicine that Affect Residency Training, in Foreman, T, Dickstein, LJ, Garakani, A (eds): A Resident s Guide to Surviving Psychiatric Training, 2 nd Edition. American Psychiatric Association, Arlington, VA, pp Smith, AG: Dealing with Managed Care in the Outpatient Setting, in Foreman, T, Dickstein, LJ, Garakni, A (eds): A Resident s Guide to Surviving Psychiatric Training, 2 nd Edition. American Psychiatric Association, Arlington, VA, pp Smith, AG: What Can I Do About the Shaking in my Hands? The Tampa Tribune (4 You), May 19, Smith, AG: What Can Be Done About Hearing Loss? The Tampa Tribune (4 You), March 3, Editorial Board Consultant, American Journal of Geriatric Pharmacotherapy Smith, AG: When Does Grieving Turn in to Depression? The Tampa Tribune (4 You), January 27, Smith, AG: Dementia Can Have a Variety of Causes. The Tampa Tribune (4 You), November 4, Smith, AG: Exercise Your Mind With Your Body. The Tampa Tribune (4 You), September 16, Smith, AG: Intimacy Doesn t Have to Decrease With Age. The Tampa Tribune (4 You), August 5, Smith, AG: Is it Time to Stop Driving? The Tampa Tribune (4 You), May 13, Reviewer for Evashwick, C: The Continuum of Long Term Care, 3 rd Ed. Thomson Delmar Learning, Clifton Park, NY, Smith, AG: Behavioral Problems in Dementia: Strategies for Pharmacologic and Nonpharmacologic Mangagement. Postgraduate Medicine 2004; 115(6): Smith, AG: Coping with the Changes in Medicine that Affect Residency Training, in Foreman El Masri, TA, Dickstein, LJ (eds): A Resident s Guide to Surviving Psychiatric Training. American Psychiatric Association, Arlington, VA, pp86 87.

19 Smith, AG: Dealing with Managed Care in the Outpatient Setting, in Foreman El Masri, TA, Dickstein, LJ (eds): A Resident s Guide to Surviving Psychiatric Training. American Psychiatric Association, Arlington, VA, pp Reviewer, Journal of Mental Health and Aging Smith, AG; Montealegre Orjuela M; Douglas JE; Jenkins EA. Venlafaxine for Pathological Crying After Stroke. Journal of Clinical Psychiatry 2003; 64(6): Smith, AG; Brauer, HR; Catalano, G; Catalano, MC. Topiramate Overdose: A Case Report and Literature Review. Epilepsy and Behavior 2001; 2(6): PERSONAL Married to Sam E. Smith (1997) Children (2): Marielle Leah Smith (2000), Madeleine Isabella Smith (2002) Hobbies and interests: arts and crafts, music, dog rescue, photography, reading, creative writing, NFL football, travel Alumnus of the Delta Alpha chapter of Alpha Delta Pi sorority REFERENCES Available upon request.